SeaStar Medical
ICU
19 hedge funds and large institutions have $49.6M invested in SeaStar Medical in 2021 Q1 according to their latest regulatory filings, with 19 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.2% more ownership
Funds ownership: 0% → 0.2% (+0.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$7.35M |
| 2 |
KIM
Karpus Investment Management
Pittsford,
New York
|
+$6.17M |
| 3 |
SCM
Saba Capital Management
New York
|
+$6.03M |
| 4 |
HSBC Holdings
London,
United Kingdom
|
+$4.9M |
| 5 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$3.92M |
Top Sellers
ICU Hedge Fund Activity: Q1 2021 in Review
19 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in SeaStar Medical (ICU) for Q1 2021, worth a combined $49.6M.
Buyers outnumbered sellers: 19 funds opened new ICU positions and 0 closed out — a net gain of 19 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $7.35M.
- 19 institutional investors held SeaStar Medical (ICU) as of Q1 2021, up from 0 in Q4 2020.
- Funds reported $49.6M of SeaStar Medical stock for Q1 2021.
- 19 funds opened new SeaStar Medical positions in Q1 2021 and 0 closed out, a net change of +19 holders.
- The largest SeaStar Medical buyer in Q1 2021 was Hudson Bay Capital Management, an estimated $7.35M added.
Based on aggregated 13F filings for Q1 2021.